Anti-Parkinson's Disease Activity of Sanghuangprous vaninii Extracts in the MPTP-Induced Zebrafish Model

被引:15
|
作者
Li, Xuezhen [1 ,2 ,3 ]
Gao, Daili [2 ]
Paudel, Yam Nath [4 ]
Li, Xia [5 ]
Zheng, Mingzhu [3 ]
Liu, Guangpeng [1 ]
Ma, Yanrui [1 ]
Chu, Le [1 ]
He, Fatao [1 ]
Jin, Meng [2 ]
机构
[1] Jinan Fruit Res Inst, All China Federat Supply & Mkt Cooperat, Jinan 250103, Shandong, Peoples R China
[2] Qilu Univ Technol, Biol Inst, Shandong Acad Sci, Jinan 250103, Shandong, Peoples R China
[3] Jilin Agr Univ, Changchun 130118, Jilin, Peoples R China
[4] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Neuropharmacol Res Strength, Bandar Sunway 47500, Selangor, Malaysia
[5] Fynn Biotechnol Ltd, Mills Inst Personalized Canc Care, Jinan 250101, Shandong, Peoples R China
来源
ACS CHEMICAL NEUROSCIENCE | 2022年 / 13卷 / 03期
关键词
Sanghuangprous vaninii; extract; Parkinson disease; MPTP; antioxidant; alpha-synuclein; OXIDATIVE STRESS; URSOLIC ACID; ANTIOXIDANT; NEUROTOXICITY; INONOTUS; NEUROINFLAMMATION; POLYSACCHARIDES; POLYPHENOLS; APOPTOSIS; BRAIN;
D O I
10.1021/acschemneuro.1c00656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) is a devastating disease of the central nervous system that occurs mainly in the elderly age group, affecting their quality of life. The PD pathogenesis is not yet fully understood and lacks the disease-modifying treatment strategies. Sanghuangprous vaninii (S. vaninii) is a perennial fungus with a plethora of pharmacological activities including anti-cancer and antioxidant activity and so on. However, no study till date has reported its neuroprotective effect against symptoms that are similar to PD in pre-clinical investigation. In the current study, we investigated anti-PD-like effects of S. vaninii mycelium extracts (SvMEs) on MPTP-induced PD in zebrafish. We observed that the loss of dopaminergic neurons and neurovascular reduction were reversed by using SvMEs in the zebrafish brain in a concentration-independent manner. Moreover, it also relieved locomotor impairments in MPTP-induced PD zebrafish. In addition, SvMEs exerted significant antioxidant activity in vitro, which was also demonstrated in vivo on ktr4:NTR-hKikGR zebrafish. Upon investigating the underlying mechanism, we found that SvMEs may alleviate oxidant stress and accelerate alpha-synuclein degradation and then alleviate PD-like symptoms. Antioxidant-related genes (sod1, gss, gpx4a, gclm, and cat) implied that the SvMEs exhibited anti-PD activity due to the antioxidation mechanism. Finally, upon analysis of chemical composition of SvMEs by liquid chromatography-mass spectrometry, we identified 10 compounds that are plausibly responsible for the anti-PD-like effect of SvMEs. On the limiting part, the finding of the study would have been more robust had we investigated the protein expression of genes related to PD and oxidative stress and compared the effects of SvMEs with any standard anti-PD therapy. Despite this, our results indicated that SvMEs possess anti-PD effects, indicating SvMEs as a potential candidate that is worth exploring further in this avenue.
引用
收藏
页码:330 / 339
页数:10
相关论文
共 50 条
  • [1] Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice
    Mani, Sugumar
    Sekar, Sathiya
    Barathidasan, Rajamani
    Manivasagam, Thamilarasan
    Thenmozhi, Arokiasamy Justin
    Sevanan, Murugan
    Chidambaram, Saravana Babu
    Essa, Musthafa Mohamed
    Guillemin, Gilles J.
    Sakharkar, Meena Kishore
    NEUROTOXICITY RESEARCH, 2018, 33 (03) : 656 - 670
  • [2] MPTP-induced mouse model of Parkinson's disease: A promising direction for therapeutic strategies
    Mustapha, Musa
    Taib, Che Norma Mat
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (04) : 422 - 433
  • [3] Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson's disease model
    Pathania, Anjana
    Kumar, Rajnish
    Sandhir, Rajat
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [4] Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson's Model
    Liu, Yingjuan
    Jin, Weihua
    Deng, Zhenzhen
    Wang, Jing
    Zhang, Quanbin
    MARINE DRUGS, 2020, 18 (09)
  • [5] Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson's disease model
    Omar, Noor Azzizah
    Kumar, Jaya
    Teoh, Seong Lin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model
    Song, Min Kyung
    Lee, Joo Hee
    Kim, Jinil
    Kim, Ji Hyun
    Hwang, Soonhye
    Kim, Yoon-Seong
    Kim, Youn-Jung
    NEUROSCIENCE LETTERS, 2021, 740
  • [7] Neuroprotective effect of marrubiin against MPTP-induced experimental Parkinson's disease in male wistar rats
    Xu, Xiaofei
    Li, Jingde
    Liu, Mingjun
    Zhang, Baoyan
    TOXICOLOGY MECHANISMS AND METHODS, 2024, 34 (08) : 908 - 919
  • [8] Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson's disease model of mice
    Haeri, Parisa
    Mohammadipour, Abbas
    Heidari, Zahra
    Ebrahimzadeh-bideskan, Alireza
    ANATOMICAL SCIENCE INTERNATIONAL, 2019, 94 (01) : 119 - 127
  • [9] Necrosis inhibitor-5 (NecroX-5), attenuates MPTP-induced motor deficits in a zebrafish model of Parkinson's disease
    Liu, Jun-Cheng
    Koppula, Sushruta
    Huh, Se-Jong
    Park, Pyo-Jam
    Kim, Chul-Geun
    Lee, Chang-Joong
    Kim, Chan-Gil
    GENES & GENOMICS, 2015, 37 (12) : 1073 - 1079
  • [10] Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson’s Disease Model in Mice
    Sugumar Mani
    Sathiya Sekar
    Rajamani Barathidasan
    Thamilarasan Manivasagam
    Arokiasamy Justin Thenmozhi
    Murugan Sevanan
    Saravana Babu Chidambaram
    Musthafa Mohamed Essa
    Gilles J. Guillemin
    Meena Kishore Sakharkar
    Neurotoxicity Research, 2018, 33 : 656 - 670